297 related articles for article (PubMed ID: 20802021)
41. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
42. Effect of oral contraceptive progestins on serum copper concentration.
Berg G; Kohlmeier L; Brenner H
Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
[TBL] [Abstract][Full Text] [Related]
43. Use of oral contraceptives and risk of breast cancer in young women.
Ursin G; Ross RK; Sullivan-Halley J; Hanisch R; Henderson B; Bernstein L
Breast Cancer Res Treat; 1998 Jul; 50(2):175-84. PubMed ID: 9822222
[TBL] [Abstract][Full Text] [Related]
44. Oral contraceptives and breast cancer: latest findings in a large cohort study.
Vessey MP; McPherson K; Villard-Mackintosh L; Yeates D
Br J Cancer; 1989 Apr; 59(4):613-7. PubMed ID: 2713247
[TBL] [Abstract][Full Text] [Related]
45. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.
Marshall LM; Spiegelman D; Goldman MB; Manson JE; Colditz GA; Barbieri RL; Stampfer MJ; Hunter DJ
Fertil Steril; 1998 Sep; 70(3):432-9. PubMed ID: 9757871
[TBL] [Abstract][Full Text] [Related]
46. Prospective study of oral contraceptive use and risk of breast cancer in women.
Romieu I; Willett WC; Colditz GA; Stampfer MJ; Rosner B; Hennekens CH; Speizer FE
J Natl Cancer Inst; 1989 Sep; 81(17):1313-21. PubMed ID: 2769784
[TBL] [Abstract][Full Text] [Related]
47. Medical contraindications and issues for consideration in the use of once-a-month injectable contraceptives.
Dorflinger LJ
Contraception; 1994 May; 49(5):455-68. PubMed ID: 8045132
[TBL] [Abstract][Full Text] [Related]
48. Oral contraceptives and the risk of ductal breast carcinoma in situ.
Claus EB; Stowe M; Carter D
Breast Cancer Res Treat; 2003 Sep; 81(2):129-36. PubMed ID: 14572155
[TBL] [Abstract][Full Text] [Related]
49. Oral contraceptives and breast cancer: review of the epidemiologic literature.
Thomas DB
Contraception; 1991 Jun; 43(6):597-642. PubMed ID: 1868735
[TBL] [Abstract][Full Text] [Related]
50. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
[TBL] [Abstract][Full Text] [Related]
51. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
52. At pill's 30th birthday, breast cancer question is unresolved.
Althaus FA; Kaeser L
Fam Plann Perspect; 1990; 22(4):173-6. PubMed ID: 2226748
[TBL] [Abstract][Full Text] [Related]
53. A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States).
Hankinson SE; Colditz GA; Manson JE; Willett WC; Hunter DJ; Stampfer MJ; Speizer FE
Cancer Causes Control; 1997 Jan; 8(1):65-72. PubMed ID: 9051324
[TBL] [Abstract][Full Text] [Related]
54. Myocardial infarction and stroke in young women: what is the impact of oral contraceptives?
Lewis MA
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S68-77. PubMed ID: 9753313
[TBL] [Abstract][Full Text] [Related]
55. A prospective study of oral contraceptives and NIDDM among U.S. women.
Chasan-Taber L; Willett WC; Stampfer MJ; Hunter DJ; Colditz GA; Spiegelman D; Manson JE
Diabetes Care; 1997 Mar; 20(3):330-5. PubMed ID: 9051382
[TBL] [Abstract][Full Text] [Related]
56. Oral contraceptive use and risk of breast carcinoma in situ.
Nichols HB; Trentham-Dietz A; Egan KM; Titus-Ernstoff L; Hampton JM; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2262-8. PubMed ID: 18006914
[TBL] [Abstract][Full Text] [Related]
57. Estrogens and breast cancer.
Hankinson SE; Stampfer MJ
Salud Publica Mex; 1997; 39(4):370-8. PubMed ID: 9337568
[TBL] [Abstract][Full Text] [Related]
58. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
Grabrick DM; Hartmann LC; Cerhan JR; Vierkant RA; Therneau TM; Vachon CM; Olson JE; Couch FJ; Anderson KE; Pankratz VS; Sellers TA
JAMA; 2000 Oct; 284(14):1791-8. PubMed ID: 11025831
[TBL] [Abstract][Full Text] [Related]
59. Oral contraceptives and breast disease in premenopausal Northern Albertan women.
Lees AW; Burns PE; Grace M
Int J Cancer; 1978 Dec; 22(6):700-7. PubMed ID: 721325
[TBL] [Abstract][Full Text] [Related]
60. Progestin-only pills for contraception.
Grimes DA; Lopez LM; O'Brien PA; Raymond EG
Cochrane Database Syst Rev; 2013 Nov; (11):CD007541. PubMed ID: 24226383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
